28.11.2011: Epimakuläre Brachytherapie:
"Einsatz außerhalb klinischer Studien nicht zu verantworten"
Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands zur
epimakulären Brachytherapie bei altersbedingter Makuladegeneration
Preliminary Program
RESEARCH INTO PRACTICE
15th Retina International World Congress
4th - 5th July 2008
Finlandia Hall, Helsinki, Finland
Quelle: http://www.retina.fi/
PRELIMINARY PROGRAM
Updated 7.2.2008
Friday 4th July
7:30 Registration
8:00 Exhibition
9:30 - 10:15 Opening session
President of Retina International Christina Fasser
President of Retina Finland Maija Lindroos
Member of Retina Finland SMAB Leila Laatikainen
10:15 - 11:00 Key note lecture:
Retinal Dystrophy Research: Alan Bird
The past, the present and the future
11:00 - 11:15 Break and exhibition
11:15 -12:55 Science block 1:
Clinical diagnostics of Retinal Dystrophies (RD)
11:15 Clinical diagnostics of RD, Sten Andreasson
11:35 Retinitis Pigmentosa (RP), Eeva-Marja Sankila
11:55 Syndromic RP, Ruth Riise
12:15 Early onset RP (LCA), Elise Heon
12:35 Best and Stargardt disease, David Birch
11:15 - 12:45 Patient block 1:
Genetics
11:15 Genotyping (DNA chip,
sequencing chip) Andreas Gal
11:45 Genetic counseling and gene tests Helena Kääriäinen
12:00 Gene therapy for RD: an Overview John Flannery
12:45 - 14:30 Lunch and exhibition
14:30 - 16:00 Science block 2:
Genetic diagnostics and research
14:30 Genetics and Genotyping of RD, Andreas Gal
15:20 Gene therapy of USH 3, John Flannery
15:40 Genetic counseling in Finland Riitta Salonen
14:30 - 16:00 Patient block 2:
Clinical aspects of RD
14:30 Diagnostics and treatment of concurrent eye diseases, Leila Laatikainen
15:00 Best and Stargardt disease David Birch
15:30 Syndromic RP Ruth Riise
14:30 - 16:00 Session for general public (admission free):
Age related macular degeneration
14:30 AMD and its risk factors, Alan Bird
15:00 Current therapy options, Petri Tommila
15:20 Is it possible to avoid AMD? Lotta Salminen
15:40 Low vision aids, Markku Leinonen
16:00 - 16:30 Coffee and exhibition
16:30 - 17:30 Plenary session:
Treatment of RD
16:30 Retinal Prosthetic Devices Mark Humayun
16:50 Stem cells Maria Thereza Perez
17:10 Clinical trials: How they are conducted, where and why? Gerald Chader
20:00 Speakers' Dinner
Saturday 5th July
7:30 Registration
8:00 Exhibition
9:30 - 10:30 Plenary session
9:30 Visual perception and daily living Markku Leinonen
9:50 Visual field defects and phenomena Lea Hyvärinen
10:10 Personal testimony Open
10:30 - 10:45 Break and exhibition
10:45 -12:15 Science block 3:
How to answer your RD patient's questions
10:45 Antioxidants, vitamins and RP Theo van Veen
11:15 What are patient registries and why are they needed Eberhart Zrenner
11:35 Preventive measures for patients Ilkka Immonen
11:55 Rehabilitation Sirkka-Liisa Rudanko
10:45 - 12:15 Patient block 3:
Rehabilitation
10:45 My life with the cane Open
11:15 Crossmodality and accessability Jukka Jokiniemi
11:45 Professional integration and rehabilitation Taru Tammi
10:45 - 12:15 Patient block 4: (in Finnish)
Ask the specialist
Aura Falck and Riitta Salonen answer questions in ophthalmology and genetics
10:45 - 12:15 Patient block 5:
Usher syndrome (USH)
10:45 Treatments for USH to come John Flannery
11:15 USH in Finland Eeva-Marja Sankila
11:35 Cochlear implants in USH Jussi Jero
11:55 Balance in USH Harri Peltola
12:15 - 14:00 Lunch and exhibition
14:00 - 15:30 Science block 4:
RD research in Finland
14:00 Retina - Basic Research Hannu Uusitalo
14:20 Inherited RD in Finland Eeva-Marja Sankila
14:40 Pharmacological therapy for RD: an Overview Arto Urtti
15:00 RD Research in Europe Eberhart Zrenner
14:00 - 15:30 Patient block 6:
Family
14:00 My Child and Retinal Dystrophy Open
14:30 Environmental description Riitta Lahtinen and
through Social-Haptics Russ Palmer
14:00 - 15:30 Patient block 7:
RD research in Europe
14:00 What does Europe do to be Andreas Gall
prepared for clinical trials?
14:30 What are patient registries and why are they needed? Sirkka-Liisa Rudanko
15:00 RD Treatments: an Overview Gerald Chader
14:00 - 15:30 Patient block 8: (in Finnish)
Ask the specialist
Maija Mäntyjärvi and Riitta Salonen answer questions
in ophthalmology and genetics
15:30 - 16:00 Break and exhibition
16:00 - 17:00 Closing session:
Ongoing treatment trials
16:00 Human Gene Therapy, Robin Ali
Leber Congenital Amaurosis
16:30 Treatment Trial with CNTF (Ciliary Neurotrophic Factor) Weng Tao
19:00 Theatre Sokkelo: Spoon River Anthology and Gala Dinner in Hotel Crowne Plaza
Gefällt Ihnen diese Seite zum Thema "Altersbedingte Makuladegeneration"? Bitte empfehlen Sie diese Informationen zur AMD dann Ihren Freunden und Bekannten:
